Highlights and Quick Summary
- Total Debt for the quarter ending June 30, 2023 was $29 Million (a -2.45% decrease compared to previous quarter)
- Year-over-year quarterly Total Debt decreased by -6.91%
- Annual Total Debt for 2022 was $30.5 Million (a -6.6% decrease from previous year)
- Annual Total Debt for 2021 was $32.6 Million (a 866.99% increase from previous year)
Visit stockrow.com/DYN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Total Debt of Dyne Therapeutics, Inc.
Most recent Total Debtof DYN including historical data for past 10 years.Interactive Chart of Total Debt of Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc. Total Debt for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $29.04 | $29.76 | – | – | – |
| 2022 | $30.48 | $31.19 | $32.83 | $32.78 | $30.48 |
| 2021 | $32.64 | $34.0 | $0.4 | $0.6 | $32.64 |
| 2020 | – | – | – | $9.94 | – |
| 2018 | – | – | – | – | $3.38 |
Business Profile of Dyne Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology